HK Stock Market Move | JINHAI MED TECH (02225) rose over 5% in the afternoon, with its share price climbing continuously after inclusion in the Stock Connect; its China medical business has achieved profitability in operations.

JINHAI MED TECH (02225) rose over 5% in the afternoon, with a cumulative gain of nearly 50% since its inclusion in Stock Connect. As of press time, it was up 5.79% at HK$6.21, with a turnover of HK$11.3564 million. On the news front, on September 7, the Shenzhen Stock Exchange announced that, in accordance with the relevant provisions of the "Shenzhen Stock Exchange Implementation Measures for the Shenzhen-Hong Kong Stock Connect Business," the list of securities eligible for Southbound Stock Connect was adjusted, effective from September 7. Among them, JINHAI MED TECH was included in the Southbound Stock Connect list. This inclusion helps broaden the shareholder base, attract long-term institutional investors, and enhance share trading liquidity. It is worth noting that in the first half of the year, JINHAI MED TECH's revenue structure was significantly optimized. Revenue related to minimally invasive surgical solutions and medical products was S$25.43 million, a sharp year-on-year increase of 301.5%, accounting for 74.73% of total revenue, and all of it came from the Chinese market. The financial report also showed that in the first half of the year, the company made a provision for China corporate income tax for the first time, meaning that Jinhai's China medical business has crossed the break-even line in operations.